Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ANI Pharma Inc
(NQ:
ANIP
)
69.15
-0.54 (-0.77%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ANI Pharma Inc
< Previous
1
2
3
4
5
Next >
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
March 11, 2024
The Nasdaq 100 closed lower by around 1.5% on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
March 05, 2024
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Drug Maker Organon Stock Scores Relative Strength Upgrade
February 28, 2024
In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday.
Via
Investor's Business Daily
ANI Pharmaceuticals's Earnings Outlook
February 28, 2024
Via
Benzinga
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
February 16, 2024
Via
Benzinga
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
November 08, 2023
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) third-quarter revenues were $131.8 million, up 57.3% Y/Y, beating the
Via
Benzinga
Expert Ratings for ANI Pharmaceuticals
October 19, 2023
Via
Benzinga
Analyst Expectations for ANI Pharmaceuticals's Future
September 13, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
August 21, 2023
Via
Benzinga
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning
August 23, 2023
Via
Investor Brand Network
7 A-Rated Biotech Stocks for Your August Buy List
August 17, 2023
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.
Via
InvestorPlace
Where ANI Pharmaceuticals Stands With Analysts
July 21, 2023
Via
Benzinga
Looking Into ANI Pharmaceuticals's Return On Capital Employed
May 23, 2023
Via
Benzinga
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 22, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 16, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Why ANI Pharmaceuticals Stock Is Soaring Today
May 08, 2023
ANI Pharmaceuticals Inc's (NASDAQ: ANIP) Q1 revenues were $106.8 million, +65.6% Y/Y, beating the
Via
Benzinga
Earnings Preview For ANI Pharmaceuticals
May 05, 2023
Via
Benzinga
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
May 15, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
May 12, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 11, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Stocks Reverse Gains Ahead Of Slew Of Inflation Data
May 08, 2023
Stocks are lower this afternoon, as investors await a deluge of inflation data amid a rally for the banking sector.
Via
Talk Markets
ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed
March 13, 2023
Via
Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 08, 2023
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 08, 2023
Via
Benzinga
ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance
May 08, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8:30 a.m. ET
April 27, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 26, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP
April 24, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP
April 04, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.